PEPG Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.60%

Insider Buying (Last 12 Months): $47,725.00

Insider Selling (Last 12 Months): $849,239.89

PepGen Insider Trading History Chart

PepGen Share Price & Price History

^$1.13

▼ -0.04 (-3.42%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

PepGen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2025	James G Mcarthur	CEO	Buy	41,500	$1.15	$47,725.00	103,913
2/26/2025	Mary Beth Delena	General Counsel	Sell	1,432	$1.68	$2,405.76	1,568
2/26/2025	Noel Donnelly	CFO	Sell	1,527	$1.68	$2,565.36	1,673
7/25/2024	Michelle L. Mellion	insider	Sell	7,571	$18.06	$136,732.26
7/18/2024	Michelle L. Mellion	insider	Sell	12,625	$18.20	$229,775.00
7/16/2024	Michelle L. Mellion	insider	Sell	5,901	$18.00	$106,218.00
7/12/2024	Michelle L. Mellion	insider	Sell	3,288	$18.04	$59,315.52
7/2/2024	Michelle L. Mellion	insider	Sell	37	$18.07	$668.59
6/24/2024	Michelle L. Mellion	insider	Sell	9,260	$18.19	$168,439.40
6/11/2024	Michelle L. Mellion	insider	Sell	500	$18.04	$9,020.00
5/17/2024	Niels Svenstrup	SVP	Sell	10,000	$13.41	$134,100.00
2/9/2024	Ra Capital Management, L.P.	Director	Buy	2,557,593	$10.64	$27,212,789.52	9,179,273
11/30/2023	James G Mcarthur	CEO	Buy	1,694	$4.17	$7,063.98	1,694
6/7/2023	James G. Mcarthur	CEO	Sell	8,419	$16.23	$136,640.37
6/5/2023	James G. Mcarthur	CEO	Sell	500	$16.06	$8,030.00
6/2/2023	James G. Mcarthur	CEO	Sell	1,800	$16.04	$28,872.00
3/24/2023	Jaya Goyal	EVP	Sell	392	$20.00	$7,840.00
2/8/2023	Jaya Goyal	EVP	Sell	644	$17.00	$10,948.00
2/6/2023	Jaya Goyal	EVP	Sell	1,677	$17.04	$28,576.08

See Full Table

SEC Filings (Institutional Ownership Changes) for PepGen (NASDAQ:PEPG)

58.01% of PepGen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

PepGen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	47,506	$0.18M	0.0%	+17.2%	0.145%
2/17/2025	Suvretta Capital Management LLC	1,174,321	$4.45M	0.2%	-29.3%	3.603%
2/17/2025	RTW Investments LP	3,193,097	$12.10M	0.2%	N/A	9.796%
2/17/2025	Orbimed Advisors LLC	653,016	$2.48M	0.1%	-18.1%	2.003%
2/17/2025	Millennium Management LLC	156,636	$0.59M	0.0%	+1,033.2%	0.481%
2/17/2025	Jacobs Levy Equity Management Inc.	136,262	$0.52M	0.0%	N/A	0.418%
2/17/2025	Janus Henderson Group PLC	522,256	$1.98M	0.0%	-77.6%	1.602%
2/17/2025	Deutsche Bank AG	44,735	$0.17M	0.0%	+442.5%	0.137%
2/17/2025	Corton Capital Inc.	17,833	$68K	0.0%	N/A	0.055%
2/17/2025	Bridgeway Capital Management LLC	98,900	$0.38M	0.0%	+103.1%	0.303%
2/17/2025	Bank of America Corp DE	53,868	$0.20M	0.0%	+54.7%	0.165%
2/14/2025	Northern Trust Corp	157,038	$0.60M	0.0%	+5.4%	0.482%
2/14/2025	Adage Capital Partners GP L.L.C.	800,000	$3.03M	0.0%	-29.0%	2.454%
2/14/2025	Dimensional Fund Advisors LP	57,102	$0.22M	0.0%	+26.2%	0.175%
2/13/2025	Walleye Capital LLC	14,418	$55K	0.0%	-76.2%	0.044%
1/24/2025	China Universal Asset Management Co. Ltd.	6,911	$26K	0.0%	N/A	0.021%
12/26/2024	JPMorgan Chase & Co.	26,611	$0.23M	0.0%	+289.9%	0.082%
11/19/2024	Barclays PLC	21,971	$0.19M	0.0%	+318.7%	0.067%
11/16/2024	Geode Capital Management LLC	375,325	$3.21M	0.0%	-1.0%	1.151%
11/15/2024	Frazier Life Sciences Management L.P.	702,694	$6.01M	0.2%	-53.2%	2.156%
11/15/2024	Barclays PLC	21,971	$0.19M	0.0%	+318.7%	0.067%
11/15/2024	XTX Topco Ltd	15,241	$0.13M	0.0%	N/A	0.047%
11/15/2024	Jane Street Group LLC	27,748	$0.24M	0.0%	+29.1%	0.085%
11/15/2024	Wellington Management Group LLP	40,517	$0.35M	0.0%	+76.9%	0.124%
11/15/2024	Janus Henderson Group PLC	2,336,516	$20.01M	0.0%	+331.2%	7.167%
11/14/2024	Walleye Capital LLC	60,654	$0.52M	0.0%	N/A	0.186%
11/14/2024	Suvretta Capital Management LLC	1,660,932	$14.20M	0.5%	+9.2%	5.095%
11/13/2024	FMR LLC	61,607	$0.53M	0.0%	-84.2%	0.189%
10/19/2024	Allspring Global Investments Holdings LLC	11,103	$95K	0.0%	N/A	0.034%
9/16/2024	Point72 DIFC Ltd	2,621	$42K	0.0%	N/A	0.008%
8/19/2024	Point72 Asset Management L.P.	145,174	$2.32M	0.0%	-24.5%	0.448%
8/14/2024	Point72 DIFC Ltd	2,621	$42K	0.0%	N/A	0.008%
8/14/2024	Marshall Wace LLP	12,251	$0.20M	0.0%	N/A	0.038%
8/10/2024	Sofinnova Investments Inc.	561,128	$8.96M	0.5%	+11.4%	1.731%
8/9/2024	Renaissance Technologies LLC	12,000	$0.19M	0.0%	N/A	0.037%
8/8/2024	American Century Companies Inc.	20,028	$0.32M	0.0%	+19.9%	0.062%
8/1/2024	Rhumbline Advisers	18,853	$0.30M	0.0%	+36.1%	0.058%
7/26/2024	Bank of New York Mellon Corp	44,157	$0.71M	0.0%	+43.6%	0.136%
5/17/2024	RA Capital Management L.P.	10,689,545	$157.14M	2.0%	+31.5%	32.972%
5/17/2024	Artal Group S.A.	200,000	$2.94M	0.1%	N/A	0.617%
5/16/2024	Janus Henderson Group PLC	1,166,642	$17.23M	0.0%	+18.1%	3.602%
5/10/2024	Acadian Asset Management LLC	2,052	$30K	0.0%	N/A	0.006%
5/10/2024	Vanguard Group Inc.	850,445	$12.50M	0.0%	+68.0%	2.626%
11/15/2023	Adage Capital Partners GP L.L.C.	680,000	$3.45M	0.0%	+18.3%	2.856%
11/13/2023	Rathbones Group PLC	62,003	$0.32M	0.0%	N/A	0.260%
11/13/2023	FMR LLC	2,365,965	$12.02M	0.0%	-13.8%	9.937%
10/27/2023	Allspring Global Investments Holdings LLC	6,564	$33K	0.0%	N/A	0.028%
10/24/2023	Bank of New York Mellon Corp	31,398	$0.16M	0.0%	-15.0%	0.132%
8/15/2023	Suvretta Capital Management LLC	486,611	$4.35M	0.2%	-41.2%	2.044%
8/4/2023	American International Group Inc.	4,837	$43K	0.0%	-33.3%	0.020%
8/2/2023	Bank of Montreal Can	199,532	$2.66M	0.0%	N/A	0.839%
3/23/2023	MetLife Investment Management LLC	8,647	$0.12M	0.0%	N/A	0.037%
11/15/2022	Parkman Healthcare Partners LLC	100,000	$0.91M	0.3%	N/A	0.423%
11/14/2022	Tudor Investment Corp Et Al	220,530	$1.57M	0.0%	-24.2%	0.933%
11/14/2022	Altium Capital Management LP	40,000	$0.36M	0.1%	-50.0%	0.169%
8/16/2022	Deerfield Management Company L.P. Series C	953,626	$9.47M	0.2%	N/A	4.036%
8/15/2022	Laurion Capital Management LP	664,516	$6.60M	0.1%	N/A	2.812%

Data available starting January 2016

See Full Table

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.

Today's Range

Now: $1.13

$1.12

$1.18

50 Day Range

MA: $1.69

$1.00

$3.15

52 Week Range

Now: $1.13

$0.88

$19.30

Volume

180,900 shs

Average Volume

806,369 shs

Market Capitalization

$36.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Who are the company insiders with the largest holdings of PepGen?: PepGen's top insider shareholders include:
Ra Capital Management, LP (Director)
James G Mcarthur (CEO)
Noel Donnelly (CFO)
Mary Beth Delena (General Counsel)
James G Mcarthur (CEO)
Michelle L Mellion (Insider)
Niels Svenstrup (SVP)
Learn More about top insider investors at PepGen.